Company Analysis
Sign in

MapLight Therapeutics, Inc. (MPLT)

Nasdaq: MPLT · Pharmaceutical Preparations · Redwood City, CA · filing with the SEC since 2019
Full chart Alerts Compare
Grade5.0
◀ Past 4.2● Present 6.6▶ Future 4.2
7 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenuen/a
Net income-$161M-107.7%
Earnings per share$-18.56+82.4%
Operating cash flow-$138M-75.3%
Cash$46.7M+22.2%
Debtn/a
Shareholders’ equity$458M+336.7%
Shares, diluted8,680,741+1079.2%
Return on equity-35.2%
The recordfrom its filings
Filings in 2026149
Newest filingOct 16 · 4
Annual reportMar 26, 2026
Quarterly reportAug 13, 2026
Next report due10-Q by Nov 14
Insider sales, 12 months$30.2M
Insider buys, 12 months$800,000
Patents granted0
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Trailing twelve months to Jun 2026Net income -$230MCash from operations -$175Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
2425
As filed, in USD. Nothing here is a forecast.

News

Oct 16, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 16, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 16, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 16, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 16, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 16, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton MPLT · research, not advice